LACTOSE (INDIA)
Back to Cashflow Statement
|
LACTOSE (INDIA) Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-5.75 Cr | ₹-8.32 Cr | ₹-8.14 Cr | ₹4.52 Cr | ₹-3.57 Cr |
What is the latest Cash Flow from Financing Activities ratio of LACTOSE (INDIA) ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-5.75 Cr |
Mar2023 | ₹-8.32 Cr |
Mar2022 | ₹-8.14 Cr |
Mar2021 | ₹4.52 Cr |
Mar2020 | ₹-3.57 Cr |
How is Cash Flow from Financing Activities of LACTOSE (INDIA) Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-5.75 Cr | Negative | |
Mar2023 | ₹-8.32 Cr | Negative | |
Mar2022 | ₹-8.14 Cr | Negative | |
Mar2021 | ₹4.52 Cr | Positive | |
Mar2020 | ₹-3.57 Cr | - |
Compare Cash Flow from Financing Activities of peers of LACTOSE (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LACTOSE (INDIA) | ₹124.5 Cr | -1.1% | -1.4% | -42.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,712.0 Cr | -1.3% | 1% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹176,623.0 Cr | -3.2% | -0.3% | 48% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,285.0 Cr | 1.2% | 10.7% | 19.5% | Stock Analytics | |
CIPLA | ₹119,010.0 Cr | -0.6% | -2.2% | -0.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,118.0 Cr | -1.5% | -5.9% | -5.1% | Stock Analytics |
LACTOSE (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LACTOSE (INDIA) | -1.1% |
-1.4% |
-42.4% |
SENSEX | 0.1% |
1% |
2.6% |
You may also like the below Video Courses